Gap finder

Search review questions

Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.

Limit to evidence status or GRADE (optional)

432 questions in 71 reviews · Neonatal

current versions
No studies 432 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

QuestionEffectEvidenceStatus / GRADE
'As needed' administration (e.g. based on pain scales) vs 'as scheduled' administration (e.g. a predefined time interval)
Major neurodevelopmental disability in children aged 18 to 24 months or three to five years old ‐ not reported · postoperative pain in neonates
Systemic opioid regimens for postoperative pain in neonates (2023) · Cochrane
no estimate extractedNRNo studies
'As needed' administration (e.g. based on pain scales) vs 'as scheduled' administration (e.g. a predefined time interval)
Cognitive and educational outcomes in children more than five years old ‐ not reported · postoperative pain in neonates
Systemic opioid regimens for postoperative pain in neonates (2023) · Cochrane
no estimate extractedNRNo studies
'As needed' administration (e.g. based on pain scales) vs 'as scheduled' administration (e.g. a predefined time interval)
Severe (defined as stage 3 or greater) retinopathy of prematurity ‐ not reported · postoperative pain in neonates
Systemic opioid regimens for postoperative pain in neonates (2023) · Cochrane
no estimate extractedNRNo studies
'As needed' administration (e.g. based on pain scales) vs 'as scheduled' administration (e.g. a predefined time interval)
Severe (grade 3 or greater) intraventricular hemorrhage (IVH) on cranial ultrasound ‐ not reported · postoperative pain in neonates
Systemic opioid regimens for postoperative pain in neonates (2023) · Cochrane
no estimate extractedNRNo studies
Continuous infusion vs bolus administration
All‐cause mortality during initial hospitalization ‐ not reported · postoperative pain in neonates
Systemic opioid regimens for postoperative pain in neonates (2023) · Cochrane
no estimate extractedNRNo studies
Continuous infusion vs bolus administration
Major neurodevelopmental disability in children aged 18 to 24 months or three to five years old ‐ not reported · postoperative pain in neonates
Systemic opioid regimens for postoperative pain in neonates (2023) · Cochrane
no estimate extractedNRNo studies
Continuous infusion vs bolus administration
Cognitive and educational outcomes in children more than five years old ‐ not reported · postoperative pain in neonates
Systemic opioid regimens for postoperative pain in neonates (2023) · Cochrane
no estimate extractedNRNo studies
Continuous infusion vs bolus administration
Severe (defined as stage 3 or greater) retinopathy of prematurity ‐ not reported · postoperative pain in neonates
Systemic opioid regimens for postoperative pain in neonates (2023) · Cochrane
no estimate extractedNRNo studies
Continuous infusion vs bolus administration
Severe (grade 3 or greater) intraventricular hemorrhage (IVH) on cranial ultrasound ‐ not reported · postoperative pain in neonates
Systemic opioid regimens for postoperative pain in neonates (2023) · Cochrane
no estimate extractedNRNo studies
'As needed' administration (e.g. based on pain scales) vs 'as scheduled' administration (e.g. a predefined time interval)
Pain · postoperative pain in neonates
Systemic opioid regimens for postoperative pain in neonates (2023) · Cochrane
no estimate extractedNRNo studies
'As needed' administration (e.g. based on pain scales) vs 'as scheduled' administration (e.g. a predefined time interval)
All‐cause mortality during initial hospitalization ‐ not reported · postoperative pain in neonates
Systemic opioid regimens for postoperative pain in neonates (2023) · Cochrane
no estimate extractedNRNo studies
Opioids vs no treatment/placebo
Parent satisfaction with care provided in the NICU (as measured by a validated instrument/tool)—not reported · neonates exposed to procedural pain
Opioids for procedural pain in neonates (2023) · Cochrane
no estimate extractedNRNo studies
Opioids vs oral sweet solution or non‐pharmacological intervention
Any harms · neonates exposed to procedural pain
Opioids for procedural pain in neonates (2023) · Cochrane
no estimate extractedNRNo studies
Opioids vs oral sweet solution or non‐pharmacological intervention
Episodes of bradycardia—not reported · neonates exposed to procedural pain
Opioids for procedural pain in neonates (2023) · Cochrane
no estimate extractedNRNo studies
Opioids vs oral sweet solution or non‐pharmacological intervention
Episodes of apnea—not reported · neonates exposed to procedural pain
Opioids for procedural pain in neonates (2023) · Cochrane
no estimate extractedNRNo studies
Opioids vs oral sweet solution or non‐pharmacological intervention
Hypotension—not reported · neonates exposed to procedural pain
Opioids for procedural pain in neonates (2023) · Cochrane
no estimate extractedNRNo studies
Opioids vs oral sweet solution or non‐pharmacological intervention
Parent satisfaction with care provided in the NICU—not reported · neonates exposed to procedural pain
Opioids for procedural pain in neonates (2023) · Cochrane
no estimate extractedNRNo studies
Opioids vs other analgesics
Any harms · procedural pain in neonates
Opioids for procedural pain in neonates (2023) · Cochrane
no estimate extractedNRNo studies
Opioids vs other analgesics
Episodes of bradycardia—not reported · procedural pain in neonates
Opioids for procedural pain in neonates (2023) · Cochrane
no estimate extractedNRNo studies
Opioids vs other analgesics
Parent satisfaction with care provided in the NICU—not reported · procedural pain in neonates
Opioids for procedural pain in neonates (2023) · Cochrane
no estimate extractedNRNo studies
Bubble vs ventilator or Infant Flow Driver nasal continuous positive airway pressure (CPAP)
Neurodevelopmental impairment · preterm infants receiving nasal CPAP
Bubble devices versus other pressure sources for nasal continuous positive airway pressure in preterm infants (2023) · Cochrane
no estimate extractedNRNo studies
NMDA receptor antagonists vs no treatment, placebo, oral sweet solution, or non‐pharmacological intervention
Pain score assessed up to 10 minutes after the procedure · Procedural pain in neonates
Non‐opioid analgesics for procedural pain in neonates (2023) · Cochrane
no estimate extractedNRNo studies
NMDA receptor antagonists vs no treatment, placebo, oral sweet solution, or non‐pharmacological intervention
Episodes of bradycardia, defined as a fall in heart rate of more than 30% below the baseline or less than 100 beats per minute for 10 seconds or longer, occurring during the procedure · Procedural pain in neonates
Non‐opioid analgesics for procedural pain in neonates (2023) · Cochrane
no estimate extractedNRNo studies
NMDA receptor antagonists vs no treatment, placebo, oral sweet solution, or non‐pharmacological intervention
Episodes of apnea (mean rates of apnea), occurring during the procedure · Procedural pain in neonates
Non‐opioid analgesics for procedural pain in neonates (2023) · Cochrane
no estimate extractedNRNo studies
NMDA receptor antagonists vs no treatment, placebo, oral sweet solution, or non‐pharmacological intervention
Hypotension requiring medical therapy (vasopressors or fluid boluses), occurring during the procedure · Procedural pain in neonates
Non‐opioid analgesics for procedural pain in neonates (2023) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Pain score assessed up to 10 minutes after the procedure · Procedural pain in neonates
Non‐opioid analgesics for procedural pain in neonates (2023) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Episodes of bradycardia, defined as a fall in heart rate of more than 30% below the baseline or less than 100 beats per minute for 10 seconds or longer, occurring during the procedure · Procedural pain in neonates
Non‐opioid analgesics for procedural pain in neonates (2023) · Cochrane
no estimate extractedNRNo studies
Caffeine vs other methylxanthines
Seizures (clinically diagnosed) · preterm infants
Caffeine versus other methylxanthines for the prevention and treatment of apnea in preterm infants (2023) · Cochrane
no estimate extractedNRNo studies
Caffeine vs other methylxanthines
Moderate to severe neurodevelopmental disability at 18 to 26 months · preterm infants
Caffeine versus other methylxanthines for the prevention and treatment of apnea in preterm infants (2023) · Cochrane
no estimate extractedNRNo studies
Caffeine vs other methylxanthines
a) Cerebral palsy · preterm infants
Caffeine versus other methylxanthines for the prevention and treatment of apnea in preterm infants (2023) · Cochrane
no estimate extractedNRNo studies
Caffeine vs other methylxanthines
b) Gross motor disability defined as ≥ level 2 according to the GMFCS · preterm infants
Caffeine versus other methylxanthines for the prevention and treatment of apnea in preterm infants (2023) · Cochrane
no estimate extractedNRNo studies
Caffeine vs other methylxanthines
d) Mental development IQ > 2 SD below the mean · preterm infants
Caffeine versus other methylxanthines for the prevention and treatment of apnea in preterm infants (2023) · Cochrane
no estimate extractedNRNo studies
Lateral decubitus position vs prone position
Episodes of bradycardia, defined as a fall in heart rate of more than 30% below the baseline or less than 100 beats per minute for 10 seconds or longer— not reported · lumbar puncture in newborn infants
Positioning for lumbar puncture in newborn infants (2023) · Cochrane
no estimate extractedNRNo studies
Lateral decubitus position vs prone position
Time to perform the lumbar puncture—not reported · lumbar puncture in newborn infants
Positioning for lumbar puncture in newborn infants (2023) · Cochrane
no estimate extractedNRNo studies
Lateral decubitus position vs prone position
Episodes of desaturation, defined as a decrease of SpO2 to less than 80%, with no minimum duration specified—not reported · lumbar puncture in newborn infants
Positioning for lumbar puncture in newborn infants (2023) · Cochrane
no estimate extractedNRNo studies
Lateral decubitus position vs prone position
Apnea: number of episodes (defined as interruption of breathing for more than 20 seconds) during the procedure—not reported · lumbar puncture in newborn infants
Positioning for lumbar puncture in newborn infants (2023) · Cochrane
no estimate extractedNRNo studies
Lateral decubitus position vs prone position
Apnea: number of infants with 1 or more episodes (defined as interruption of breathing for more than 20 seconds) during the procedure—not reported · lumbar puncture in newborn infants
Positioning for lumbar puncture in newborn infants (2023) · Cochrane
no estimate extractedNRNo studies
Lateral decubitus position vs sitting position
Total number of lumbar puncture attempts (successful or unsuccessful)—not reported · lumbar puncture in newborn infants
Positioning for lumbar puncture in newborn infants (2023) · Cochrane
no estimate extractedNRNo studies
Lateral decubitus position vs sitting position
Apnea: number of infants with 1 or more episodes (defined as interruption of breathing for more than 20 seconds) during the procedure—not reported · lumbar puncture in newborn infants
Positioning for lumbar puncture in newborn infants (2023) · Cochrane
no estimate extractedNRNo studies
Lateral decubitus position vs prone position
Total number of lumbar puncture attempts—not reported · lumbar puncture in newborn infants
Positioning for lumbar puncture in newborn infants (2023) · Cochrane
no estimate extractedNRNo studies
Topical anesthetics vs placebo or no intervention
Apnea: number of episodesduring the procedure · newborn infants undergoing lumbar puncture
Pharmacological interventions for the management of pain and discomfort during lumbar puncture in newborn… (2023) · Cochrane
no estimate extractedNRNo studies
Early paracetamol vs placebo/no intervention
All‐cause mortality during initial hospital stay (by clinical assessment) · preterm or low birth weight infants with PDA
Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants (2022) · Cochrane
no estimate extractedNRNo studies
Early paracetamol vs placebo/no intervention
Necrotizing enterocolitis during initial hospital stay (by radiological diagnosis) · preterm or low birth weight infants with PDA
Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants (2022) · Cochrane
no estimate extractedNRNo studies
Late paracetamol vs placebo/no intervention
All‐cause mortality during initial hospital stay (by clinical assessment) · preterm or low birth weight infants with PDA
Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants (2022) · Cochrane
no estimate extractedNRNo studies
Paracetamol plus ibuprofen (oral or IV) vs ibuprofen plus placebo (oral or IV) or no intervention
All‐cause mortality during initial hospital stay (by clinical assessment) · preterm or low birth weight infants with PDA
Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants (2022) · Cochrane
no estimate extractedNRNo studies
Prophylactic administration of paracetamol vs placebo or no intervention
Necrotizing enterocolitis during initial hospital stay (by radiological diagnosis) · preterm infants with PDA
Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants (2022) · Cochrane
no estimate extractedNRNo studies
Turning position vs supine under phototherapy
Need for exchange transfusion · term and preterm neonates with hyperbilirubinaemia
Periodic change of body position under phototherapy in term and preterm neonates with hyperbilirubinaemia (2022) · Cochrane
no estimate extractedNRNo studies
Turning position vs supine under phototherapy
Bilirubin‐induced neurological damage (BIND) · term and preterm neonates with hyperbilirubinaemia
Periodic change of body position under phototherapy in term and preterm neonates with hyperbilirubinaemia (2022) · Cochrane
no estimate extractedNRNo studies
Turning position vs supine under phototherapy
Sudden infant death syndrome (SIDS) · term and preterm neonates with hyperbilirubinaemia
Periodic change of body position under phototherapy in term and preterm neonates with hyperbilirubinaemia (2022) · Cochrane
no estimate extractedNRNo studies
Synbiotics vs control
Neurodevelopmental impairment (assessed beyond infancy) · very preterm or very low birth weight infants
Synbiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants (2022) · Cochrane
no estimate extractedNRNo studies